A woman comes to see me three weeks into chemotherapy for breast cancer. She has done her homework. She lays a bag on the table: high-dose vitamin C, vitamin E, NAC, a beta-carotene complex, a greens powder that promises to flood her cells with protection. She takes all of it, every day, because everything she read told her antioxidants fight cancer. She is trying so hard to help her body. And I have to tell her that some of what is in that bag may be working against the treatment she sat in the infusion chair for that morning.
This is the most misunderstood topic in my field. Antioxidants carry a reputation as something close to universally good, the more the better. The real story is that they are dose-dependent and context-dependent, and there are settings where loading up on them is the wrong move.
Your cells produce reactive oxygen species as a normal part of being alive, and antioxidants keep those in check. Cancer cells, though, often run hot with oxidative stress already, and that is something we can use. Radiation and many chemotherapy drugs kill cancer cells partly by driving reactive oxygen species past what the cell can survive. Flood the body with high-dose antioxidants during that window and you may be handing the tumor exactly the buffer it needs to make it through.
Large prevention trials that expected good news taught us this the hard way. In the ATBC trial, beta-carotene supplementation raised lung cancer rates in smokers. CARET tested beta-carotene with vitamin A and was stopped early because the supplemented group had more lung cancer and higher mortality. SELECT found that vitamin E supplementation increased prostate cancer risk. These were large, rigorous trials built to show benefit, and they showed harm.
The laboratory work points the same direction. In animal models, antioxidants like NAC and vitamin E have accelerated the progression and spread of lung cancer and melanoma. That is animal data, and I hold it loosely until we see the same thing in people. But it lines up with the mechanism, and that combination is enough to make me careful. An analysis from the SWOG S0221 chemotherapy trial found that breast cancer patients who used antioxidant supplements during treatment tended to have worse outcomes. That study shows association, not causation. Still, when the trials, the biology, and the treatment data all tell a similar story, we listen.
There is a deeper version of this story that almost nobody is telling patients, and I think it matters. Your body runs its own internal antioxidant defense system through a transcription factor called NRF2. NRF2 senses oxidative stress and switches on a fleet of protective genes, and several of the food compounds I love, sulforaphane from broccoli sprouts, curcumin, EGCG from green tea, work largely through it. Activating NRF2 in healthy cells is part of why those foods earn their reputation in prevention.
Here is the twist. Once a tumor exists, it can hijack the same system. A subset of lung cancers carry KEAP1 mutations that lock NRF2 permanently on, and those tumors are notoriously harder to treat with chemotherapy and radiation because the cancer cell is already running its antioxidant defenses at full tilt. The pathway we cheer on for prevention is the pathway some established cancers use to survive treatment.
I do not read this as a reason to stop eating broccoli. I read it as a reason to stop pretending prevention biology and treatment biology are the same biology. Pumping in heroic doses of concentrated NRF2 activators during chemo or radiation deserves attention and pause.
Here is the distinction that resolves most of the confusion. The antioxidants in vegetables, fruit, herbs, and tea are consistently tied to lower cancer risk. The failures and the warning signs come from isolated compounds at pharmacologic doses in a capsule.
Food delivers these molecules in physiologic amounts, packaged with cofactors, in a form your body has spent a very long time learning to handle. A supplement delivers a single compound at a dose you would never reach by eating. Same molecule, completely different signal to the body. When I tell a patient to eat widely and in color, I mean it. When I see the megadose capsules, that is a different conversation.
People always ask about high-dose IV vitamin C here, and it deserves a quick answer. At the concentrations reached through an IV, vitamin C stops behaving like an antioxidant and acts as a pro-oxidant, which is the opposite mechanism. Different route, different dose, different biology.
Bottom line:
Skip the megadose vitamin C, E, and beta-carotene taken just in case. Just in case is not a reason, and in this case it may be a risk.
During radiation and chemotherapies that work through oxidative stress, I pause high-dose isolated antioxidant supplements and want food-based antioxidants in their place.
For prevention, I do not recommend high-dose single-antioxidant supplements. Topical antioxidants are fine. The goal is plenty of antioxidants from food.
In survivorship, specific antioxidants, at specific times, for specific reasons, do have a role, particularly to address treatment-related reactive oxygen species and ongoing inflammation.
These choices belong with your oncology team and a clinician who knows your full picture. If you are in or near cancer treatment and you have a supplement drawer, bring it to your next appointment. Every bottle. Including the gummies. Most of those are worthless anyway.
Sometimes too much of a good thing can be harmful.
Ksenia Malarkey, ND is a naturopathic physician specializing in integrative oncology, hormones, and metabolic health.
She provides medical care for Washington residents and offers global health coaching.
To schedule a free 15-minute consult, visit drkseniamalarkey.com